Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mohamed A Abdelgawad, Mohammad M Al-Sanea, Arafa Musa, Mohammed Elmowafy, Ashraf K El-Damasy, Amany A Azouz, Mohammed M Ghoneim & Rania B Bakr. (2022) Docking Study, Synthesis, and Anti-Inflammatory Potential of Some New Pyridopyrimidine-Derived Compounds. Journal of Inflammation Research 15, pages 451-463.
Read now
Read now
Josiane V. Cruz, Silvana Giuliatti, Levy B. Alves, Raí C. Silva, Elenilze F. B. Ferreira, Njogu M. Kimani, Carlos H. T. P. Silva, João S. N. de Souza, José M. Espejo-Román & Cleydson B. R. Santos. (2022) Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches. Journal of Biomolecular Structure and Dynamics 40:12, pages 5386-5408.
Read now
Read now
Amira Atef Ghoneim, Ahmed Foud El-Farargy & Rania B. Bakr. (2022) Design, Synthesis, Molecular Docking of Novel Substituted Pyrimidinone Derivatives as Anticancer Agents. Polycyclic Aromatic Compounds 42:5, pages 2538-2554.
Read now
Read now
Amira A. Ghoneim, Nadia Ali Ahmed Elkanzi & Rania B. Bakr. (2018) Synthesis and studies molecular docking of some new thioxobenzo[g]pteridine derivatives and 1,4-dihydroquinoxaline derivatives with glycosidic moiety. Journal of Taibah University for Science 12:6, pages 774-782.
Read now
Read now
Articles from other publishers (30)
Akshun Vyas, Bhaskar Sahu, Shelly Pathania, Nilay Kumar Nandi, Gaurav Chauhan, Vivek Asati & Bhupinder Kumar. (2022) An insight on medicinal attributes of pyrimidine scaffold: An updated review. Journal of Heterocyclic Chemistry 60:7, pages 1081-1121.
Crossref
Crossref
Ruba A. Alolayan, Nadia Ali Ahmed Elkanzi, Hajer Hrichi & Rania B. Bakr. (2023) Design, Synthesis, Docking Study of Pyrazolohydrazinopyrimidin‐4‐one Derivatives and Their Application as Antimicrobials. Chemistry & Biodiversity 20:5.
Crossref
Crossref
Md. Jahangir Alam, Ozair Alam, Mohd. Javed Naim, Farah Nawaz, Ajay Manaithiya, Mohd Imran, Hamdy Khamees Thabet, Sultan Alshehri, Mohammed M. Ghoneim, Prawez Alam & Faiyaz Shakeel. (2022) Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics. Molecules 27:24, pages 8708.
Crossref
Crossref
Sahaya Nadar & Tabassum Khan. (2021) Pyrimidine: An elite heterocyclic leitmotif in drug discovery‐synthesis and biological activity. Chemical Biology & Drug Design 100:6, pages 818-842.
Crossref
Crossref
Noor ul Amin Mohsin, Sana Aslam, Matloob Ahmad, Muhammad Irfan, Sami A. Al-Hussain & Magdi E. A. Zaki. (2022) Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities. Pharmaceuticals 15:12, pages 1471.
Crossref
Crossref
Khaled R.A. Abdellatif, Eman K.A. Abdelall, Phoebe F. Lamie, Madlen B. Labib, Marwa M. Abdelhakeem, Maha M. Abdel-Fattah & El-Shaymaa El-Nahaas. (2022) Novel pyrazole-oxadiazole hybrids possessing methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies. Journal of Molecular Structure 1266, pages 133529.
Crossref
Crossref
Mohamed A. Abdelgawad, Nadia A.A. Elkanzi, Arafa Musa, Mohammed M. Ghoneim, Waqas Ahmad, Mohammed Elmowafy, Ahmed M. Abdelhaleem Ali, Ahmed H. Abdelazeem, Syed N.A. Bukhari, Mohamed El-Sherbiny, Mohammed A.S. Abourehab & Rania B. Bakr. (2022) Optimization of pyrazolo[1,5-a]pyrimidine based compounds with pyridine scaffold: Synthesis, biological evaluation and molecular modeling study. Arabian Journal of Chemistry 15:8, pages 104015.
Crossref
Crossref
Mohamed A. Abdelgawad, Nadia A.A. Elkanzi, A.A. Nayl, Arafa Musa, Nasser Hadal Alotaibi, W.A.A. Arafa, Sobhi M. Gomha & Rania B. Bakr. (2022) Targeting tumor cells with pyrazolo[3,4-d]pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms. Arabian Journal of Chemistry 15:5, pages 103781.
Crossref
Crossref
Ahmed Fekri, Eman M. Keshk, Abdel-Galil M. Khalil & Israa Taha. (2021) Synthesis of novel antioxidant and antitumor 5-aminopyrazole derivatives, 2D/3D QSAR, and molecular docking. Molecular Diversity 26:2, pages 781-800.
Crossref
Crossref
Frédéric Lecornué & Bastien Michelet. 2022. Comprehensive Heterocyclic Chemistry IV. Comprehensive Heterocyclic Chemistry IV
403
457
.
Mohamed A. Mohamed Teleb, Ahmed E. M. Mekky & Sherif M. H. Sanad. (2021)
3‐Aminothieno
[2,3‐
b
]pyridine‐2‐carboxylate: Effective precursor for microwave‐assisted three components synthesis of new pyrido[3′,2′:4,5]thieno[3,2‐
d
]pyrimidin‐4(
3
H
)‐one hybrids
. Journal of Heterocyclic Chemistry 58:9, pages 1825-1835.
Crossref
Crossref
Khaled R. A. Abdellatif, Eman K. A. Abdelall, Heba A. H. Elshemy, El‐Shaymaa El‐Nahass, Maha M. Abdel‐Fattah & Yasmin Y. M. Abdelgawad. (2020) New indomethacin analogs as selective COX‐2 inhibitors: Synthesis, COX‐1/2 inhibitory activity, anti‐inflammatory, ulcerogenicity, histopathological, and docking studies. Archiv der Pharmazie 354:4, pages 2000328.
Crossref
Crossref
Haroon ur Rashid, Marco Antonio Utrera Martines, Adriana Pereira Duarte, Juliana Jorge, Shagufta Rasool, Riaz Muhammad, Nasir Ahmad & Muhammad Naveed Umar. (2021) Research developments in the syntheses, anti-inflammatory activities and structure–activity relationships of pyrimidines. RSC Advances 11:11, pages 6060-6098.
Crossref
Crossref
Volodymyr Ya. HorishnyPavlo V. Zadorozhnii, Ivanna V. HorishniaVasyl S. Matiychuk. (2020) Synthesis, Anti-Inflammatory Activity and Molecular Docking Studies of 1,4,5,6-Tetrahydropyrimidine-2-Carboxamides. Pharmaceutical Sciences 27:3, pages 353-365.
Crossref
Crossref
Ranjana Aggarwal, Pawan Kaushik, Ajay Kumar & Deepika Saini. (2020) Design, Synthesis and Biological Evaluation of
5-amino-3-aryl-1-(6'-chloropyridazin-3'-yl)pyrazoles
and their Derivatives as Analgesic Agents. Drug Research 70:11, pages 493-502.
Crossref
Crossref
Marwa F. Harras, Rehab Sabour & Omkulthom Mohamed Alkamali. (2019) Discovery of new non-acidic lonazolac analogues with COX-2 selectivity as potent anti-inflammatory agents. MedChemComm 10:10, pages 1775-1788.
Crossref
Crossref
Khaled R.A. Abdellatif, Wael A.A. Fadaly, Yaser A. Mostafa, Dana M. Zaher & Hany A. Omar. (2019) Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities. Bioorganic Chemistry 91, pages 103132.
Crossref
Crossref
Khaled RA Abdellatif, Mohammed T El-Saadi, Shaimaa G Elzayat & Noha H Amin. (2019) New substituted pyrazole derivatives targeting COXs as potential safe anti-inflammatory agents. Future Medicinal Chemistry 11:15, pages 1871-1882.
Crossref
Crossref
Vrinda Sharma, Parth Bhatia, Ozair Alam, Mohd. Javed Naim, Farah Nawaz, Aadil Ahmad Sheikh & Mukund Jha. (2019) Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies (2008–2019). Bioorganic Chemistry 89, pages 103007.
Crossref
Crossref
Rania B. Bakr, Amira A. Ghoneim & Amany A. Azouz. (2019) Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold. Bioorganic Chemistry 88, pages 102964.
Crossref
Crossref
Noha H Amin, Mohammed T El-Saadi, Ahmed A Hefny, Ahmed H Abdelazeem, Heba AH Elshemy & Khaled RA Abdellatif. (2018) Anti-inflammatory indomethacin analogs endowed with preferential COX-2 inhibitory activity. Future Medicinal Chemistry 10:21, pages 2521-2535.
Crossref
Crossref
Xiaoyu Liu, Xizhong Song, Yuwen Liu, Mingjin Xie, Wei Yu, Shengjiao Yan, Jun Lin & Yi Jin. (2018) Novel 5H-[1,2,4]oxadiazolo[4,5-a]pyrimidin-5-one derivatives as antibacterial and anticancer agents: Synthesis and biological evaluation. Tetrahedron Letters 59:42, pages 3767-3772.
Crossref
Crossref
Khaled R.A. Abdellatif & Rania B. Bakr. (2018) New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds. Bioorganic Chemistry 78, pages 341-357.
Crossref
Crossref
Mohamed A. Abdelgawad, Rania B. Bakr & Amany A. Azouz. (2018) Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability. Bioorganic Chemistry 77, pages 339-348.
Crossref
Crossref
Rania B. Bakr, Nadia A. A. Elkanzi, Amira A. Ghoneim & Shaima M. N. Moustafa. (2018) Synhesis, Molecular Docking Studies and in vitro Antimicrobial Evaluation of Novel Pyrimido[1,2-a]quinoxaline and Triazino[4,3-a]quinoxaline Derivatives. HETEROCYCLES 96:11, pages 1941.
Crossref
Crossref
Mohamed A Abdelgawad, Rania B Bakr, Ahmed O El-Gendy, Gehan M Kamel, Amany A Azouz & Syed Nasir Abbas Bukhari. (2017) Discovery of a COX-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effect. Future Medicinal Chemistry 9:16, pages 1899-1912.
Crossref
Crossref
Yun-Jeong Heo & Moon-Kook Jeon. (2017) A novel solid-phase synthetic method for production of N -alkyl-4-alkylamino-1-aryl-1 H -pyrazolo[3,4- d ]pyrimidine-6-carboxamide library. Tetrahedron 73:40, pages 5959-5973.
Crossref
Crossref
Mohamed A. Abdelgawad, Rania B. Bakr & Hany A. Omar. (2017) Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Bioorganic Chemistry 74, pages 82-90.
Crossref
Crossref
Khosrow Kashfi & Mahnoush Esmaili. 2017. Nitric Oxide as a Chemosensitizing Agent. Nitric Oxide as a Chemosensitizing Agent
105
142
.
Khosrow Kashfi & Pascale L. Duvalsaint. 2017. Nitric Oxide Donors. Nitric Oxide Donors
75
119
.